Literature DB >> 12462875

Secretion rate from minor salivary glands in patients with malignant haematological diseases receiving chemotherapy--a pilot study.

Johan Blomgren1, Sigbritt Jansson, Stig Rödjer, Dowen Birkhed.   

Abstract

The aim of this pilot study was to investigate the secretion rate from minor salivary glands in 16 patients (mean age 62 years) with myeloma, lymphoma or other malignant haematological diseases receiving chemotherapy (study group). An age- and sex-matched control group (n = 16) was recruited. The secretion rate from the minor salivary glands on the inside of the lower lip, measured using the Periotron method, was in mean 2.8 microliters/cm2/min in the study group compared with 4.5 microliters/cm2/min in the control group (p < 0.01). No difference was found in the secretion rate of paraffin-stimulated whole saliva. There were more individuals who experienced dry mouth in the study group (n = 7) than in the control group (n = 2). The conclusion from this pilot study is that the secretion rate from the minor salivary glands might be reduced in cancer patients treated with chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12462875

Source DB:  PubMed          Journal:  Swed Dent J        ISSN: 0347-9994


  2 in total

Review 1.  A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.

Authors:  S B Jensen; A M L Pedersen; A Vissink; E Andersen; C G Brown; A N Davies; J Dutilh; J S Fulton; L Jankovic; N N F Lopes; A L S Mello; L V Muniz; C A Murdoch-Kinch; R G Nair; J J Napeñas; A Nogueira-Rodrigues; D Saunders; B Stirling; I von Bültzingslöwen; D S Weikel; L S Elting; F K L Spijkervet; M T Brennan
Journal:  Support Care Cancer       Date:  2010-03-17       Impact factor: 3.603

2.  Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy.

Authors:  Velia Ramírez-Amador; Gabriela Anaya-Saavedra; Erick Crespo-Solís; Esther Irigoyen Camacho; Imelda González-Ramírez; Sergio Ponce-de-León
Journal:  Support Care Cancer       Date:  2009-08-06       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.